Qiming Venture Partners
Edit

Qiming Venture Partners

https://qimingvc.com/
Last activity: 03.03.2025
Active
Invests in categories: ServiceHealthTechTechnologyPlatformMedTechProductDevelopmentDrugResearchProvider
Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong, Seattle, Boston and the San Francisco Bay Area.

Currently Qiming Venture Partners manages nine US Dollar funds and six RMB funds with $5.9 billion in assets under management. Since our establishment, we have invested in outstanding companies in the TMT and healthcare industries at the early and growth stages.

Since our debut, we have backed over 380 fast-growing and innovative companies. Over 130 companies are already listed on NYSE, NASDAQ, HKEx, Gretai Securities Market, Shanghai Stock Exchange and Shenzhen Stock Exchange, or achieved exit through M&A and other means. There are also over 40 portfolio companies that have achieved unicorn status.

Many of our portfolio companies are today's most influential firms in their respective sectors, including Xiaomi (SEHK:1810), Meituan (SEHK:3690), Bilibili (NASDAQ:BILI, SEHK:9626), Roborock (SHSE:688169), Gan & Lee Pharmaceuticals (SHSE: 603087), Tigermed (SZSE:300347, SEHK:3347), Zai Lab (NASDAQ:ZLAB, SEHK:9688), Venus MedTech (SEHK:2500), CanSino Biologics (SEHK:6185, SHSE:688185), Schrödinger (NASDAQ:SDGR), APT Medical (SHSE:688617), Sanyou Medical (SHSE:688085), New Horizon Health (SEHK:6606), AmoyDx (SZSE:300685), Berry Genomics (SZSE:000710), SinocellTech (SHSE: 688520), WeDoctor Group, and UBTech among many others.
News
483
Portfolio
393
Mentions
103
Location: China, Shanghai
Employees: 51-200
Founded date: 2006
Investment Type: Venture Capital
Investment Stage: Series A; Series B; Series C; Series D

Portfolio 393

DateNameWebsiteTotal RaisedLocation
31.01.2024Synapsorsynapsor.com-China, Bei...
23.01.2024QuantaSingliangzizhige.com-China, Bei...
23.01.2024Structure ...structuretx.com$580.4MUnited Sta...
23.01.2024Novoprotei...novoprotein.com.cn--
23.01.2024Arrail Gro...arrailgroup.com-China, Bei...
23.01.2024Tuhu.comtuhu.cn$100MChina, Min...
20.01.2024one-chipone-chip.com-China, Jia...
20.01.2024Prismlabprismlab.cn--
20.01.2024M20 Genomi...m20genomics.com-China, Zhe...
20.01.2024BlockVisio...blockvision.org$5MSingapore
Show more

News 483

DateTitleDescription
17.11.2023Clinical Proteomics Startup Complete Omics Inc. Successfully Completes Series A Financing, Exclusively Invested by Qiming Venture Partners-
11.11.2023Qiming Monthly Newsletter (October 2023)-
26.10.2023Innovation and Technology Venture Fund adds two co-investment partners-
17.10.2023Qiming Monthly Newsletter (September 2023)-
29.09.2023Qiming Venture Partners' Portfolio Company Tuhu Car Successfully Listed on the Hong Kong Stock Exchange-
06.09.2023Qiming Monthly Newsletter (August 2023)-
06.09.2023Qiming Monthly Newsletter (July 2023)-
31.08.2023Epigenic Therapeutics Announces $32M in Series A Funding-
18.08.2023July 2023 Qiming Newsletter-
30.07.2023Qiming Venture Partners Appoints James Shen as Venture Partner-
Show more

Mentions in press and media 103

DateTitleDescription
03.03.2025Pulnovo Medical Announces Closing of Nearly $100 Million Series C FinancingSHANGHAI, March 3, 2025 /PRNewswire/ -- Pulnovo Medical, a globally recognized pioneer in medical devices for pulmonary hypertension (PH) and heart failure (HF), has announced the closing of nearly $100 million Series C financing. This roun...
25.02.2025Chip firm Biren plans Hong Kong IPO to raise $300 million funding, sources sayChinese chip company Biren Technology is planning a Hong Kong IPO to raise around $300 million and is working with China International Capital Corporation, Bank of China International, and Ping An Securities on the potential stock sale, whi...
19.02.2025China Digest: Nisa Leung departs from Qiming; Hony Capital to manage new Qianhai fundNisa Leung has officially stepped down from her position as a managing partner of Qiming Venture Partners, while China’s Hony Capital is the manager of a new fund.
14.02.2025Deals in brief: Finmo’s Series A round hits oversubscription, Giftaway and HD raise fresh capital, latest China deals, and moreFinmo raises Series A funding to expand treasury management platform Finmo, a treasury operating system provider, has raised USD 18.5 million in an oversubscribed Series A funding round, bringing its total funding to USD 27 million. The rou...
13.02.2025New Blood in Innovation: Frank Yin Joins Washington Research FoundationIn the bustling world of innovation, fresh talent can spark a revolution. Frank Yin, Ph.D., is the latest addition to the Washington Research Foundation (WRF) as an investment associate. His mission? To unearth and nurture startup opportuni...
13.02.2025Frank Yin joins Washington Research Foundation staff as investment associateWashington Research Foundation Yin's role will primarily focus on identifying and evaluating startup investment opportunities to advance Washington state innovations for public benefit SEATTLE, Feb. 13, 2025 /PRNewswire-PRWeb/ -- Frank Yin,...
20.01.2025Umoja Biopharma's $100 Million Leap: A New Era for In Vivo CAR T Cell TherapiesUmoja Biopharma is on the rise. The Seattle-based company has just secured $100 million in Series C financing. This is not just a number; it’s a statement. It signals a bold step forward in the world of biotechnology. The funding round was ...
20.01.2025Umoja Biopharma Raises $100M in Series C FinancingUmoja Biopharma, a Seattle, WA-based clinical-stage company which specializes in vivo cell therapies, raised $100M Series C financing. The round was led by Double Point Ventures and DCVC Bio, with participation from new and existing investo...
14.01.2025Windward Bio: Charting New Waters in Immunology with $200 Million Series A FinancingIn the vast ocean of biopharmaceutical innovation, Windward Bio has set sail with a robust $200 million Series A financing. This private, clinical-stage company aims to navigate the turbulent waters of immunological diseases, focusing on se...
13.01.2025PE major EQT anchors Cornerstone Robotics's $70m fundingSwedish investment house EQT Group has anchored the $70-million Series C funding round in Hong Kong-headquartered surgical robotics firm Cornerstone Robotics, according to an announcement. The round also saw the participation of a number of...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In